/ Prof Alexis Turgeon
Dr. Turgeon practices Critical Care Medicine and Anesthesiology at the CHU de Québec – Université Laval (Hôpital de l’Enfant-Jésus) in Québec City, Québec, Canada. He graduated from medical school at Université Laval in 1999. Following his residency training in Anesthesiology, he completed a master’s degree in Clinical Epidemiology. He pursued training in Critical Care Medicine at the University of Ottawa and research fellowship at the Clinical Epidemiology Unit of the Ottawa Hospital Research Institute. He is a scientist in the Trauma-Emergency-Critical Care Medicine Unit of the Population Health and Optimal Health Practices Axis at the CHU de Québec-Université Laval Research Centre.
Alexis Turgeon is Associate Professor and Director of Research in the Department of Anesthesiology and Critical Care Medicine at Université Laval. He Co-founded the Perioperative Anesthesia Clinical Trials (PACT) Group and the Canadian Traumatic Brain Injury Research Consortium (CTRC) that he Co-Chairs. He is the Director of Cochrane Canada Francophone.
Dr. Turgeon is the Chairholder of the Canada Research Chair in Critical Care Neurology and Trauma. He leads the CIHR-funded TBI-Prognosis Study, a pan-Canadian study aiming to develop a prognostic model of long-term prognosis following severe TBI. He leads the TBI-QualE Study aiming to understand the determinants of the decision to withdraw life-sustaining therapies in this population. He developed a research program on the use of blood products in critically ill patients. He leads the HEMOTION trial, a CIHR-funded multicenter RCT on RBC transfusion thresholds in TBI (co-Pls Lauzier, Fergusson). He conducts a vast research program in knowledge synthesis of prognostic markers and interventions in critically ill patients with TBI. Dr. Turgeon is funded by a CIHR Foundation Scheme grant and a Canada Foundation for Innovation (CFI) grant to develop the Patient-Oriented Practice-Based Research Unit for Optimal Practices in Critical Care Neurology and Trauma.